Stock Track | Collegium Pharmaceutical Soars 8.46% in Pre-market on Strong Q1 Results and Guidance Reaffirmation

Stock Track05-07

Collegium Pharmaceutical's stock surged 8.46% in pre-market trading following the release of better-than-expected first quarter 2026 financial results.

The biopharmaceutical company reported quarterly revenue of $193.5 million, beating analyst estimates of $186 million and representing a 9% year-over-year increase. Adjusted earnings per share came in at $1.76, exceeding the consensus estimate of $1.59 and marking an 18% improvement from the same period last year.

Key growth drivers included JORNAY PM, which saw net revenue jump 36% year-over-year to $38.9 million, with prescriptions reaching an all-time high. The company also reaffirmed its full-year 2026 guidance and reported progress on its planned acquisition of AZSTARYS, which is expected to close in the second quarter and be immediately accretive to adjusted EBITDA.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181417026?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 20:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181417026","market":"hk","top_or_hot":-1,"title":"Stock Track | Collegium Pharmaceutical Soars 8.46% in Pre-market on Strong Q1 Results and Guidance Reaffirmation","media":"Stock Track","content":"<p>Collegium Pharmaceutical's stock surged 8.46% in pre-market trading following the release of better-than-expected first quarter 2026 financial results.</p><p>The biopharmaceutical company reported quarterly revenue of $193.5 million, beating analyst estimates of $186 million and representing a 9% year-over-year increase. Adjusted earnings per share came in at $1.76, exceeding the consensus estimate of $1.59 and marking an 18% improvement from the same period last year.</p><p>Key growth drivers included JORNAY PM, which saw net revenue jump 36% year-over-year to $38.9 million, with prescriptions reaching an all-time high. The company also reaffirmed its full-year 2026 guidance and reported progress on its planned acquisition of AZSTARYS, which is expected to close in the second quarter and be immediately accretive to adjusted EBITDA.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Collegium Pharmaceutical Soars 8.46% in Pre-market on Strong Q1 Results and Guidance Reaffirmation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Collegium Pharmaceutical Soars 8.46% in Pre-market on Strong Q1 Results and Guidance Reaffirmation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-07 20:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Collegium Pharmaceutical's stock surged 8.46% in pre-market trading following the release of better-than-expected first quarter 2026 financial results.</p><p>The biopharmaceutical company reported quarterly revenue of $193.5 million, beating analyst estimates of $186 million and representing a 9% year-over-year increase. Adjusted earnings per share came in at $1.76, exceeding the consensus estimate of $1.59 and marking an 18% improvement from the same period last year.</p><p>Key growth drivers included JORNAY PM, which saw net revenue jump 36% year-over-year to $38.9 million, with prescriptions reaching an all-time high. The company also reaffirmed its full-year 2026 guidance and reported progress on its planned acquisition of AZSTARYS, which is expected to close in the second quarter and be immediately accretive to adjusted EBITDA.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COLL","symbol_name":"Collegium Pharmaceutical, Inc.","start_time":0,"source_url":"","article_id":"1181417026","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181417026","pubTimestamp":1778158779,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Collegium Pharmaceutical's stock surged 8.46% in pre-market trading following the release of better-than-expected first quarter 2026 financial results.The biopharmaceutical company reported quarterly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COLL":"Collegium Pharmaceutical, Inc."},"translate_title":"个股追踪|Collegium Pharmaceutical盘前大涨8.46%Q1业绩强劲且指引重申","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COLL":1},"content_text":"Collegium Pharmaceutical's stock surged 8.46% in pre-market trading following the release of better-than-expected first quarter 2026 financial results.The biopharmaceutical company reported quarterly revenue of $193.5 million, beating analyst estimates of $186 million and representing a 9% year-over-year increase. Adjusted earnings per share came in at $1.76, exceeding the consensus estimate of $1.59 and marking an 18% improvement from the same period last year.Key growth drivers included JORNAY PM, which saw net revenue jump 36% year-over-year to $38.9 million, with prescriptions reaching an all-time high. The company also reaffirmed its full-year 2026 guidance and reported progress on its planned acquisition of AZSTARYS, which is expected to close in the second quarter and be immediately accretive to adjusted EBITDA.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181417026","isCrawlerRequest":true}